Wheezing clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Daily OM-85 in Young Children With Recurrent Wheezing
open to eligible people ages 6 months to 72 months
This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing
at UCSF
Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
Sorry, in progress, not accepting new patients
The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation period off therapy.
at UCSF
Last updated: